In vitro studies have demonstrated, that anti-spike immune serum enhanced the infection of immune cells by SARS-CoV Spike-pseudotyped lentiviral particles, as well as replication-competent SARS-CoV, via Fcγ receptor II (FcγRII), but not ACE2 [111,112]. The gene discussed is ACE2; the disease is infection.